Partnership combines Xbrane’s protein-expression system with Stada’s management teams
News
Bristol Myers Squibb opens 125-acre biologics campus in Dublin
Facility also includes a cell culture suite, quality control laboratories and technology labs
Brainomix and Visionable announce AI partnership
Link up will take on bottlenecks in time-sensitive stroke care pathway across the UK
EnteroBiotix announces partnership with Imperial College London
Collaboration includes a phase 2 clinical trial using microbiome therapeutics funded by the MRC
MHRA extends Cosentyx licence for paediatric arthritis
Data demonstrates that secukinumab shows a significantly longer time to flare versus placebo
Positive results for Ipsen’s metastatic pancreatic cancer treatment
Onivyde regimen demonstrated statistically significant improvement in overall survival
EIT Health’s Venture Centre of Excellence in link-up with ProductLife
ProductLife becomes partner in upholding regulatory and compliance across life sciences
SMC expands guidance for Lokelma to emergency care settings
New access to treatment involves adult patients with hyperkalaemia across Scotland
Rivus presents results from trial evaluating controlled metabolic accelerator
HU6 data demonstrates significant selective weight loss across all body compartments
AstraZeneca’s Farxiga data shows widespread undiagnosed chronic kidney disease
INSIDE-CKD study involves patients from across France, Germany, Italy, the US and Japan
Leva Clinic fundraises £3m for UK’s first digital chronic pain platform
Funding will be used to broaden partnerships with the NHS and improve patient experience
Digital cognitive behaviour therapies recommended by NICE across the NHS
Treatment will assist young people and children with symptoms of mild-to-moderate anxiety
Lhasa and Optibrium improve predictive modelling for drug-metabolising enzymes
Research shows how novel predictive models develop drug design and reduce toxicity
Xerion and MDC secure vital brain tumour treatment funding
Grant from Innovate UK SMART awarded to accelerate clinical trial progress
Aelix and Gilead announce results of HIV infection candidate
The study evaluated the safety, efficacy and immunogenicity of AELIX’s HIV vaccine
